Penelope Harakidas

422 total citations
9 papers, 348 citations indexed

About

Penelope Harakidas is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Penelope Harakidas has authored 9 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Penelope Harakidas's work include Bone health and treatments (3 papers), Prostate Cancer Treatment and Research (3 papers) and Peptidase Inhibition and Analysis (2 papers). Penelope Harakidas is often cited by papers focused on Bone health and treatments (3 papers), Prostate Cancer Treatment and Research (3 papers) and Peptidase Inhibition and Analysis (2 papers). Penelope Harakidas collaborates with scholars based in Canada and United States. Penelope Harakidas's co-authors include Shafaat A. Rabbani, Jack Henkin, Donald J. Davidson, Andrew P. Mazar, David Goltzman, Bruce M. Jamison, Julienne Gladu, Terry L. Bowlin, Alaka Mullick and Serge Picard and has published in prestigious journals such as Infection and Immunity, International Journal of Cancer and Molecular and Cellular Endocrinology.

In The Last Decade

Penelope Harakidas

9 papers receiving 335 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Penelope Harakidas 155 136 114 79 75 9 348
S. Carrère 68 0.4× 291 2.1× 91 0.8× 80 1.0× 93 1.2× 9 474
Erik Corcoran 189 1.2× 215 1.6× 84 0.7× 89 1.1× 86 1.1× 12 481
Takashi Tsuruo 241 1.6× 217 1.6× 32 0.3× 54 0.7× 29 0.4× 18 404
Mona Ahmed 126 0.8× 180 1.3× 45 0.4× 44 0.6× 32 0.4× 10 328
Anette Heller 188 1.2× 152 1.1× 83 0.7× 30 0.4× 33 0.4× 13 365
Adi Nagler 103 0.7× 212 1.6× 59 0.5× 26 0.3× 39 0.5× 11 369
Arthur Y. Elliott 141 0.9× 212 1.6× 77 0.7× 21 0.3× 77 1.0× 26 516
Concetta Ragone 174 1.1× 274 2.0× 94 0.8× 43 0.5× 35 0.5× 27 464
Bos Jl 118 0.8× 256 1.9× 53 0.5× 13 0.2× 44 0.6× 13 390
Y. Yamashita 122 0.8× 108 0.8× 25 0.2× 24 0.3× 127 1.7× 28 386

Countries citing papers authored by Penelope Harakidas

Since Specialization
Citations

This map shows the geographic impact of Penelope Harakidas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Penelope Harakidas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Penelope Harakidas more than expected).

Fields of papers citing papers by Penelope Harakidas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Penelope Harakidas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Penelope Harakidas. The network helps show where Penelope Harakidas may publish in the future.

Co-authorship network of co-authors of Penelope Harakidas

This figure shows the co-authorship network connecting the top 25 collaborators of Penelope Harakidas. A scholar is included among the top collaborators of Penelope Harakidas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Penelope Harakidas. Penelope Harakidas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Mullick, Alaka, Miria Elias, Serge Picard, et al.. (2004). Dysregulated Inflammatory Response toCandida albicansin a C5-Deficient Mouse Strain. Infection and Immunity. 72(10). 5868–5876. 62 indexed citations
2.
Mullick, Alaka, Miria Elias, Penelope Harakidas, et al.. (2003). GeneExpression in HL60 Granulocytoids and Human PolymorphonuclearLeukocytes Exposed toCandidaalbicans. Infection and Immunity. 72(1). 414–429. 28 indexed citations
3.
Rabbani, Shafaat A., et al.. (2000). Synthetic inhibitor of matrix metalloproteases decreases tumor growth and metastases in a syngeneic model of rat prostate cancerin vivo. International Journal of Cancer. 87(2). 276–282. 39 indexed citations
4.
Rabbani, Shafaat A., Julienne Gladu, Penelope Harakidas, Bruce M. Jamison, & David Goltzman. (1999). Over-production of parathyroid hormone-related peptide results in increased osteolytic skeletal metastasis by prostate cancer cellsIn vivo. International Journal of Cancer. 80(2). 257–264. 70 indexed citations
5.
Harakidas, Penelope, et al.. (1999). Regulated expression of HIV-1 Rev function in mammalian cell lines. Canadian Journal of Microbiology. 45(6). 480–490. 7 indexed citations
6.
Rabbani, Shafaat A., Julienne Gladu, Penelope Harakidas, Bruce M. Jamison, & David Goltzman. (1999). Over‐production of parathyroid hormone–related peptide results in increased osteolytic skeletal metastasis by prostate cancer cells In vivo. International Journal of Cancer. 80(2). 257–264. 4 indexed citations
7.
Rabbani, Shafaat A., et al.. (1998). Effect of nucleoside analogue BCH-4556 on prostate cancer growth and metastases in vitro and in vivo.. PubMed. 58(15). 3461–5. 35 indexed citations
8.
Rabbani, Shafaat A., Penelope Harakidas, Julienne Gladu, et al.. (1997). Expression and characterization of recombinant rat parathyroid hormone-related peptide (1–141) and an amino-terminally-truncated analogue (38–141). Molecular and Cellular Endocrinology. 130(1-2). 13–21. 2 indexed citations
9.
Rabbani, Shafaat A., Penelope Harakidas, Donald J. Davidson, Jack Henkin, & Andrew P. Mazar. (1995). Prevention of prostate‐cancer metastasis in vivo by a novel synthetic inhibitor of urokinase‐type plasminogen activator (uPA). International Journal of Cancer. 63(6). 840–845. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026